Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

40.45
BATS BZX Real-Time Price
As of 1:23pm ET
 -0.21 / -0.52%
Today’s Change
36.81
Today|||52-Week Range
44.50
-5.16%
Year-to-Date
2 Reasons Why Alnylam Pharmaceuticals Stock Gained 18.5% in November
12:36pm / MotleyFool.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Tuesday
Dec 06 / TheStreet.com - Paid Partner Content
Actelion is a Perfect Fit for Sanofi but Probably too Expensive: Exane BNP
9:43am / TheStreet.com - Paid Partner Content
Actelion Surges on Report of Sanofi Challenge to J&J Takeover Bid
Dec 06 / TheStreet.com - Paid Partner Content
Sanofi and Johnson & Johnson May Battle for the Right to Overpay for Actelion
7:34am / MotleyFool.com - Paid Partner Content
European Stocks Slip Lower, Italy Gains in Mixed Start to Trading
Dec 06 / TheStreet.com - Paid Partner Content
Novo Nordisk Files Regulatory Application for Semaglutide
Dec 06 / Zacks.com - Paid Partner Content
Here's Why Regeneron Pharmaceuticals, Inc. Jumped 9.4% in November
Dec 05 / MotleyFool.com - Paid Partner Content
Better Buy: MannKind Corp. vs. Novo Nordisk
Dec 06 / MotleyFool.com - Paid Partner Content
Alnylam Reports Positive Data on Fitusiran, Givosiran
Dec 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close40.66
Today’s open40.83
Day’s range40.02 - 40.83
Volume159,534
Average volume (3 months)2,332,618
Market cap$104.7B
Dividend yield4.11%
Data as of 1:23pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-17.98%
Earnings growth (this year)--
Earnings growth (next 5 years)+3.40%
Revenue growth (last year)-14.57%
P/E ratio25.4
Price/Sales2.96
Price/Book1.66

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-1.63-2.65%
BMYBristol-Myers Squibb-1.38-2.46%
GSKGlaxoSmithKline-0.15-0.40%
CELGCelgene-5.31-4.52%
Data as of 1:23pm ET, 12/07/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.66
Annual revenue (last year)$38.1B
Annual profit (last year)$4.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts


Search for Jobs